Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Article |
|
|
Transforming the clinical data management process with Agile
The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission.
|
|
|
|
|
|
Industry Insights |
|
|
|
|
In R&D, The UK Is Not Nearly As Far Ahead As Other Countries
To surpass Israel as the country with highest R&D expenditure, UK needs to devote an additional £62 billion this year from public-private sectors, as per IPPR data.
|
|
|
|
|
|
Biologics Offshore Likely To Grow In 2023, CPHI Study Claims
A report that was released just in time for CPHI Frankfurt, made the prediction that biologics outsourcing will soar in 2023, as China innovation engine pauses.
|
|
|
|
|
|
|
|
|
|
Biopharma Mergers and Acquisitions on a Rise
As established firms look to new biotechs for innovation, Pharma M&A has grown considerably with a focus on immune system ailments, cancer, and rare diseases.
|
|
|
|
|
|
FDA Under Pressure To Alter Accelerated Approval Program
Fact that advisory group chose to take big steps shows how hard it is for regulatory authorities to ensure drugs quickly record their safety and effectiveness.
|
|
|
|
|
|
COVID-19 Updates |
|
|
|
|
Omicron Subvariants Are Immune To Major Antibody Therapies
Omicron subvariants diminish the effectiveness of the antibody treatments, which have been essential in safeguarding those having compromised immune systems.
|
|
|
|
|
|
China Releases The First COVID Vaccination That Is Inhaled
The new vaccination, which will be administered concurrently with the standard injectable dosages, is being offered at a number of hospitals across the country.
|
|
|
|
|